Crossmark

Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis

Crossref DOI link: https://doi.org/10.1007/s00535-023-01976-x

Published Online: 2023-03-09

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fu, Yizhen

Peng, Wei

Zhang, Weixiang

Yang, Zhenyun

Hu, Zili

Pang, Yanxun

Hu, Dandan

Chen, Jinbin

Wang, Juncheng

Zhou, Zhongguo

Xu, Li

Chen, Minshan

Zhang, Yaojun
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81874070)
License Information

Text and Data Mining valid from 2023-03-09

Version of Record valid from 2023-03-09
More Information

Article History

Received: 3 October 2022

Accepted: 21 February 2023

First Online: 9 March 2023

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below